Cargando…
Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience
Objective: In this study, we aimed to compare [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging to detect lesions in multiple myeloma. Methods: A total of 14 patients with multiple myeloma who underwent [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging were included in this retrospective study. SUV(max) val...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875266/ https://www.ncbi.nlm.nih.gov/pubmed/35202189 http://dx.doi.org/10.3390/tomography8010024 |
_version_ | 1784657877245362176 |
---|---|
author | Elboga, Umut Sahin, Ertan Cayirli, Yusuf Burak Okuyan, Merve Aktas, Gokmen Haydaroglu Sahin, Handan Dogan, Ilkay Kus, Tulay Akkurd, Dervis Murat Cimen, Ufuk Mumcu, Vuslat Kilbas, Benan Celen, Yusuf Zeki |
author_facet | Elboga, Umut Sahin, Ertan Cayirli, Yusuf Burak Okuyan, Merve Aktas, Gokmen Haydaroglu Sahin, Handan Dogan, Ilkay Kus, Tulay Akkurd, Dervis Murat Cimen, Ufuk Mumcu, Vuslat Kilbas, Benan Celen, Yusuf Zeki |
author_sort | Elboga, Umut |
collection | PubMed |
description | Objective: In this study, we aimed to compare [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging to detect lesions in multiple myeloma. Methods: A total of 14 patients with multiple myeloma who underwent [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging were included in this retrospective study. SUV(max) values of [68Ga]FAPI and [18F]FDG were compared according to lesion locations. Also, lesion localization ability of both imaging methods was compared on the patient basis. Results: In 4 of 14 patients, [68Ga]FAPI PET/CT and [18F]FDG PET/CT have not detected any bone lesions. In 8 of the remaining 10 patients [18F]FDG PET/CT detected bone lesions but in this group, 6 patients showed more higher SUV(max) values than [18F]FDG PET/CT in [68Ga]FAPI PET/CT.In contrast, 2 of 8 patients showed more higher SUV(max) values than [68Ga]FAPI PET/CT in [18F]FDG PET/CT. Moreover, [68Ga]FAPI PET/CT detected bone lesions in two patients, which werenot detected by [18F]FDG PET/CT. Also, in five patients, [68Ga]FAPI PET/CT showed more bone lesions in comparison with[18F]FDG PET/CT. Only one patient, [18F]FDG PET/CT showed more bone lesions. Three extramedullary involvements were observed in the following locations: lung, presacral lymph node, and soft tissue mass lateral to the right maxillary sinus. Among these involvements, higher SUV(max) values were observed in the lung and presacral lymph node with [68Ga]FAPI compared to [18F]FDG. However, the soft tissue mass showed a higher SUV(max) value in [18F]FDG than [68Ga]FAPI. Conclusions: No significant superiority was observed in [68Ga]FAPI PET/CT over [18F]FDG PET/CT in patients with MM. However, [68Ga]FAPI PET/CT can be utilized as a complementary imaging method to [18F]FDG PET/CT in some settings, especially in low-[18F]FDG affinity and inconclusive cases. Considering the favorable aspects of [68Ga]FAPI PET/CT in MM, such as low background activity, absence of non-specific bone marrow, and physiological brain involvement, further studies with a larger sample size should be conducted. |
format | Online Article Text |
id | pubmed-8875266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88752662022-02-26 Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience Elboga, Umut Sahin, Ertan Cayirli, Yusuf Burak Okuyan, Merve Aktas, Gokmen Haydaroglu Sahin, Handan Dogan, Ilkay Kus, Tulay Akkurd, Dervis Murat Cimen, Ufuk Mumcu, Vuslat Kilbas, Benan Celen, Yusuf Zeki Tomography Article Objective: In this study, we aimed to compare [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging to detect lesions in multiple myeloma. Methods: A total of 14 patients with multiple myeloma who underwent [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging were included in this retrospective study. SUV(max) values of [68Ga]FAPI and [18F]FDG were compared according to lesion locations. Also, lesion localization ability of both imaging methods was compared on the patient basis. Results: In 4 of 14 patients, [68Ga]FAPI PET/CT and [18F]FDG PET/CT have not detected any bone lesions. In 8 of the remaining 10 patients [18F]FDG PET/CT detected bone lesions but in this group, 6 patients showed more higher SUV(max) values than [18F]FDG PET/CT in [68Ga]FAPI PET/CT.In contrast, 2 of 8 patients showed more higher SUV(max) values than [68Ga]FAPI PET/CT in [18F]FDG PET/CT. Moreover, [68Ga]FAPI PET/CT detected bone lesions in two patients, which werenot detected by [18F]FDG PET/CT. Also, in five patients, [68Ga]FAPI PET/CT showed more bone lesions in comparison with[18F]FDG PET/CT. Only one patient, [18F]FDG PET/CT showed more bone lesions. Three extramedullary involvements were observed in the following locations: lung, presacral lymph node, and soft tissue mass lateral to the right maxillary sinus. Among these involvements, higher SUV(max) values were observed in the lung and presacral lymph node with [68Ga]FAPI compared to [18F]FDG. However, the soft tissue mass showed a higher SUV(max) value in [18F]FDG than [68Ga]FAPI. Conclusions: No significant superiority was observed in [68Ga]FAPI PET/CT over [18F]FDG PET/CT in patients with MM. However, [68Ga]FAPI PET/CT can be utilized as a complementary imaging method to [18F]FDG PET/CT in some settings, especially in low-[18F]FDG affinity and inconclusive cases. Considering the favorable aspects of [68Ga]FAPI PET/CT in MM, such as low background activity, absence of non-specific bone marrow, and physiological brain involvement, further studies with a larger sample size should be conducted. MDPI 2022-02-01 /pmc/articles/PMC8875266/ /pubmed/35202189 http://dx.doi.org/10.3390/tomography8010024 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Elboga, Umut Sahin, Ertan Cayirli, Yusuf Burak Okuyan, Merve Aktas, Gokmen Haydaroglu Sahin, Handan Dogan, Ilkay Kus, Tulay Akkurd, Dervis Murat Cimen, Ufuk Mumcu, Vuslat Kilbas, Benan Celen, Yusuf Zeki Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience |
title | Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience |
title_full | Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience |
title_fullStr | Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience |
title_full_unstemmed | Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience |
title_short | Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience |
title_sort | comparison of [68ga]-fapi pet/ct and [18f]-fdg pet/ct in multiple myeloma: clinical experience |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875266/ https://www.ncbi.nlm.nih.gov/pubmed/35202189 http://dx.doi.org/10.3390/tomography8010024 |
work_keys_str_mv | AT elbogaumut comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT sahinertan comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT cayirliyusufburak comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT okuyanmerve comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT aktasgokmen comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT haydaroglusahinhandan comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT doganilkay comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT kustulay comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT akkurddervismurat comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT cimenufuk comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT mumcuvuslat comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT kilbasbenan comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience AT celenyusufzeki comparisonof68gafapipetctand18ffdgpetctinmultiplemyelomaclinicalexperience |